Valeant

  www.valeant.com
  www.valeant.com

Valeant Reviews

46 Reviews
2.5
46 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Valeant Chairman and CEO Mike Pearson
Mike Pearson
32 Ratings
  1.  

    Fast Paced

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Senior Systems Tech in Hayward, CA
    Current Employee - Senior Systems Tech in Hayward, CA

    I have been working at Valeant full-time (more than 3 years)

    Pros

    learning to work in fast paced environment, learn new technologies, project management, and team skills

    Cons

    Overseas communication due to different work hours

    Advice to ManagementAdvice

    Doing well. More resources would be beneficial to better control projects.

    Recommends
    Positive Outlook
    Approves of CEO

Valeant Interviews

Updated Sep 9, 2014
Updated Sep 9, 2014

Interview Experience

Interview Experience

50%
25%
25%

Getting an Interview

Getting an Interview

28%
20%
20%

Interview Difficulty

2.5
Average

Interview Difficulty

Hard

Average

Easy
  1.  

    Sales Representative Interview

    Anonymous Employee
    Anonymous Employee
    Interview Details

    I had to go through two rounds of phone interviews which then resulted in them inviting me out to Rochester, NY for a final interview. It was split up into two parts, behavioral and past sales experience.

    Interview Questions
    • What qualities do you have that would make you a good salesman?   Answer Question
    Declined Offer

Valeant Awards & Accolades

Let us know if we're missing any workplace or industry recognition – Add an award

Additional Info

Unlock Profile
Website www.valeant.com
Headquarters Laval, Canada
Size 1000 to 5000 Employees
Founded Unknown
Type Company - Public (VRX)
Industry Biotech & Pharmaceuticals
Revenue $2 to $5 billion (USD) per year

Valeant Pharmaceuticals is in the anti-virus business, but don't look for its goods in the software aisle. The firm makes about 390 prescription and OTC drugs focusing on the areas of neurology and dermatology. It sells its products in North America and Central Europe, and in Brazil and Australia. Major Valeant drugs include skin cancer therapy Efudix; Mestinon, a treatment for severe muscle weakness; and epilepsy treatment Diastat. The company also earns income from partnerships with GlaxoSmithKline, for epilepsy treatment retigabine, and Schering-Plough for anti-viral... More

Work at Valeant? Share Your Experiences

Valeant

 
Click to Rate
or